Information about Wezefarma
My details
*
*
*

Company information

Status
Active

Enterprise number

BE0466.775.480

VAT liability
Yes
Established
20-08-1999
Last balance sheet year
2024
Company size
Small 2 FTE
Commercial name
Wezefarma Bv
Principal activity
Retail sale of pharmaceutical products
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from Wezefarma

2024 2023 2022 2021
Profit/Loss 162,418 13 % 144,085 27 % 113,824 76 % 64,615
Equity 377,576 -1 % 380,158 2 % 373,072 2 % 364,248
Gross margin 368,730 11 % 333,183 17 % 285,945 24 % 231,124
Employees 2 1.9 1.6 1.7

Publications from Wezefarma

Date Publication
19-10-2020 Modification Legal Form - Resignations - Appointments (NL)
14-10-2019 Resignations - Appointments (NL)
01-06-2017 Registered Office (NL)
01-09-2014 Resignations - Appointments (NL)
03-11-2008 Articles of Association (Translation, Coordination, Other Modifications, .) - Capital - Shares (NL)

Frequently asked questions

What is the VAT number of Wezefarma?
The VAT number of Wezefarma is BE 0466.775.480.
Wat is the PEPPOL ID of Wezefarma?
The PEPPOL ID of Wezefarma is 0208:0466775480. Log in or start a free trial to see the full overview.
When was Wezefarma founded?
Wezefarma was founded on 20-08-1999.
What is the address of Wezefarma?
The current registered office of Wezefarma is located at Aarschotsesteenweg 154/2, 3111 Rotselaar.
When was the last time Wezefarma filed their annual financial statements?
The most recent financial statements of Wezefarma were filed on 11-12-2024.
How many employees does Wezefarma have?
There are 2 FTEs working at Wezefarma according to the staff figures in the most recent financial statements.
What is the annual turnover of Wezefarma?
At the time of its most recent financial statements, Wezefarma did not publish any turnover figures. Wezefarma reported a gross margin of €368,730.34.